SEC Form 4 · accession 0001079974-15-000249
OMNI BIO PHARMACEUTICAL, INC. · OMBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BOCO Investments LLC
10% Owner
Period of report
Jun 15, 2010
Accepted (ET)
Apr 9, 2015 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001389870
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $0.50 | Jun 15, 2010 | J | 2,900,000 | D | Mar 31, 2009 | Mar 31, 2014 | Common Stock | 2,900,000 | 7,450,000 | D |
| Warrant | $1.00 | Jun 15, 2010 | J | 1,450,000 | D | Mar 31, 2009 | Mar 31, 2014 | Common Stock | 1,450,000 | 7,450,000 | D |
| Warrant | $0.25 | Jun 15, 2010 | J | 2,900,000 | A | Mar 31, 2009 | Mar 31, 2014 | Common Stock | 2,900,000 | 7,450,000 | D |
| Warrant | $0.25 | Jun 15, 2010 | J | 1,450,000 | A | Mar 31, 2009 | Mar 31, 2014 | Common Stock | 1,450,000 | 7,450,000 | D |
| Warrant | $0.25 | Jul 30, 2013 | J | 2,900,000 | D | Mar 31, 2009 | Mar 31, 2014 | Common Stock | 2,900,000 | 7,450,000 | D |
| Warrant | $0.25 | Jul 30, 2013 | J | 1,450,000 | D | Mar 31, 2009 | Mar 31, 2014 | Common Stock | 1,450,000 | 7,450,000 | D |
| Warrant | $0.25 | Jul 30, 2013 | J | 2,900,000 | A | Mar 31, 2009 | Mar 31, 2017 | Common Stock | 2,900,000 | 7,450,000 | D |
| Warrant | $1.00 | Jul 30, 2013 | J | 1,450,000 | A | Mar 31, 2009 | Mar 31, 2017 | Common Stock | 1,450,000 | 7,450,000 | D |
| Warrant | $0.50 | Dec 31, 2013 | E | 100,000 | D | Mar 31, 2009 | Dec 31, 2013 | Common Stock | 100,000 | 7,350,000 | D |
Explanation of responses
- F1This Warrant amends and restates in its entirety a previously reported Warrant for the same number of shares for the purpose of removing a restriction on exercise based on aggregate beneficial ownership.
- F2This Warrant amends and restates in its entirety a previous Warrant for the same number of shares for the purpose of extending the contractual period to March 31, 2017.
- F3Warrant Expired 12/31/2013.